Sleep-wake disturbance in patients with brain tumors

Terri S. Armstrong, Marcia Y. Shade, Ghislain Breton, Mark R. Gilbert, Anita Mahajan, Michael E. Scheurer, Elizabeth Vera, Ann Malone Berger

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Sleep-wake disturbances are defined as perceived or actual alterations in sleep that result in impaired daytime functioning. Unlike other cancers, there is limited information about sleep-wake disturbances in adults with primary brain tumors throughout the illness trajectory. Sleep-wake disturbance is among the most severe and common symptoms reported by primary brain-tumor patients, particularly those undergoing radiation therapy. As with other cancers and neurologic illness, sleep-wake disturbance may also be clustered or related to other symptoms such as fatigue, depression, and cognitive impairment. There is increasing evidence for a genetic basis of normal sleep and sleep regulation in healthy adults. Specific mutations and single nucleotide variants have been reported to be associated with both fatigue and sleep-wake disorders, and both inflammation and alterations in circadian rhythms have been postulated to have a potential role. Guidelines for assessment and interventions have been developed, with cognitive behavioral therapy, exercise, and sleep hygiene demonstrating benefit in patients with other solid tumors. Further research is needed to identify risk and appropriate treatment in the brain-tumor patient population.

Original languageEnglish (US)
Pages (from-to)323-335
Number of pages13
JournalNeuro-Oncology
Volume19
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Brain Neoplasms
Sleep
Fatigue
Neoplasms
Cognitive Therapy
Circadian Rhythm
Nervous System
Radiotherapy
Nucleotides
Guidelines
Exercise
Depression
Inflammation
Mutation
Research
Population

Keywords

  • Braintumor
  • Hypersomnia
  • Insomnia
  • Radiation
  • Sleep-wark
  • Symptoms
  • Therapy

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Armstrong, T. S., Shade, M. Y., Breton, G., Gilbert, M. R., Mahajan, A., Scheurer, M. E., ... Berger, A. M. (2017). Sleep-wake disturbance in patients with brain tumors. Neuro-Oncology, 19(3), 323-335. https://doi.org/10.1093/neuonc/now119

Sleep-wake disturbance in patients with brain tumors. / Armstrong, Terri S.; Shade, Marcia Y.; Breton, Ghislain; Gilbert, Mark R.; Mahajan, Anita; Scheurer, Michael E.; Vera, Elizabeth; Berger, Ann Malone.

In: Neuro-Oncology, Vol. 19, No. 3, 01.03.2017, p. 323-335.

Research output: Contribution to journalArticle

Armstrong, TS, Shade, MY, Breton, G, Gilbert, MR, Mahajan, A, Scheurer, ME, Vera, E & Berger, AM 2017, 'Sleep-wake disturbance in patients with brain tumors', Neuro-Oncology, vol. 19, no. 3, pp. 323-335. https://doi.org/10.1093/neuonc/now119
Armstrong TS, Shade MY, Breton G, Gilbert MR, Mahajan A, Scheurer ME et al. Sleep-wake disturbance in patients with brain tumors. Neuro-Oncology. 2017 Mar 1;19(3):323-335. https://doi.org/10.1093/neuonc/now119
Armstrong, Terri S. ; Shade, Marcia Y. ; Breton, Ghislain ; Gilbert, Mark R. ; Mahajan, Anita ; Scheurer, Michael E. ; Vera, Elizabeth ; Berger, Ann Malone. / Sleep-wake disturbance in patients with brain tumors. In: Neuro-Oncology. 2017 ; Vol. 19, No. 3. pp. 323-335.
@article{acb035f20af44d9aa29c2e5b29de6080,
title = "Sleep-wake disturbance in patients with brain tumors",
abstract = "Sleep-wake disturbances are defined as perceived or actual alterations in sleep that result in impaired daytime functioning. Unlike other cancers, there is limited information about sleep-wake disturbances in adults with primary brain tumors throughout the illness trajectory. Sleep-wake disturbance is among the most severe and common symptoms reported by primary brain-tumor patients, particularly those undergoing radiation therapy. As with other cancers and neurologic illness, sleep-wake disturbance may also be clustered or related to other symptoms such as fatigue, depression, and cognitive impairment. There is increasing evidence for a genetic basis of normal sleep and sleep regulation in healthy adults. Specific mutations and single nucleotide variants have been reported to be associated with both fatigue and sleep-wake disorders, and both inflammation and alterations in circadian rhythms have been postulated to have a potential role. Guidelines for assessment and interventions have been developed, with cognitive behavioral therapy, exercise, and sleep hygiene demonstrating benefit in patients with other solid tumors. Further research is needed to identify risk and appropriate treatment in the brain-tumor patient population.",
keywords = "Braintumor, Hypersomnia, Insomnia, Radiation, Sleep-wark, Symptoms, Therapy",
author = "Armstrong, {Terri S.} and Shade, {Marcia Y.} and Ghislain Breton and Gilbert, {Mark R.} and Anita Mahajan and Scheurer, {Michael E.} and Elizabeth Vera and Berger, {Ann Malone}",
year = "2017",
month = "3",
day = "1",
doi = "10.1093/neuonc/now119",
language = "English (US)",
volume = "19",
pages = "323--335",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Sleep-wake disturbance in patients with brain tumors

AU - Armstrong, Terri S.

AU - Shade, Marcia Y.

AU - Breton, Ghislain

AU - Gilbert, Mark R.

AU - Mahajan, Anita

AU - Scheurer, Michael E.

AU - Vera, Elizabeth

AU - Berger, Ann Malone

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Sleep-wake disturbances are defined as perceived or actual alterations in sleep that result in impaired daytime functioning. Unlike other cancers, there is limited information about sleep-wake disturbances in adults with primary brain tumors throughout the illness trajectory. Sleep-wake disturbance is among the most severe and common symptoms reported by primary brain-tumor patients, particularly those undergoing radiation therapy. As with other cancers and neurologic illness, sleep-wake disturbance may also be clustered or related to other symptoms such as fatigue, depression, and cognitive impairment. There is increasing evidence for a genetic basis of normal sleep and sleep regulation in healthy adults. Specific mutations and single nucleotide variants have been reported to be associated with both fatigue and sleep-wake disorders, and both inflammation and alterations in circadian rhythms have been postulated to have a potential role. Guidelines for assessment and interventions have been developed, with cognitive behavioral therapy, exercise, and sleep hygiene demonstrating benefit in patients with other solid tumors. Further research is needed to identify risk and appropriate treatment in the brain-tumor patient population.

AB - Sleep-wake disturbances are defined as perceived or actual alterations in sleep that result in impaired daytime functioning. Unlike other cancers, there is limited information about sleep-wake disturbances in adults with primary brain tumors throughout the illness trajectory. Sleep-wake disturbance is among the most severe and common symptoms reported by primary brain-tumor patients, particularly those undergoing radiation therapy. As with other cancers and neurologic illness, sleep-wake disturbance may also be clustered or related to other symptoms such as fatigue, depression, and cognitive impairment. There is increasing evidence for a genetic basis of normal sleep and sleep regulation in healthy adults. Specific mutations and single nucleotide variants have been reported to be associated with both fatigue and sleep-wake disorders, and both inflammation and alterations in circadian rhythms have been postulated to have a potential role. Guidelines for assessment and interventions have been developed, with cognitive behavioral therapy, exercise, and sleep hygiene demonstrating benefit in patients with other solid tumors. Further research is needed to identify risk and appropriate treatment in the brain-tumor patient population.

KW - Braintumor

KW - Hypersomnia

KW - Insomnia

KW - Radiation

KW - Sleep-wark

KW - Symptoms

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=85019657671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019657671&partnerID=8YFLogxK

U2 - 10.1093/neuonc/now119

DO - 10.1093/neuonc/now119

M3 - Article

C2 - 27286798

AN - SCOPUS:85019657671

VL - 19

SP - 323

EP - 335

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 3

ER -